REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that the New York State Department of Health has issued Pathwork Diagnostics a clinical laboratory permit and approved the offering of the company’s Tissue of Origin testing service to New York State residents. The Pathwork Tissue of Origin Test helps identify the origin of challenging tumors and increases pathologists’ and oncologists’ confidence in the cancer diagnosis. The permit establishes the test as the only FDA-cleared tissue of origin testing service available in New York State.
